Abstract
Since 2007 the Czech Republic has witnessed a significant increase in the problem use of methamphetamine (known locally as “pervitin”), which is associated with major harm to mental health. Methamphetamine users account for approximately 70% of the patients in treatment for addiction to illegal drugs. A great proportion of them show additional psychiatric disorders which preceded or were induced by drug use (they include psychotic conditions, depressive and anxiety disorders, personality disorders, ADHD, and eating disorders). While psychiatric comorbidity in methamphetamine users is a major issue which addiction treatment needs to address, relevant evidence and information from clinical practice have been scarce in the Czech Republic. This review summarises both national and international findings concerning psychiatric comorbidity in methamphetamine users.
| Translated title of the contribution | Psychiatric comorbidity in metamphetamine users |
|---|---|
| Original language | Slovak |
| Pages (from-to) | 26-35 |
| Number of pages | 10 |
| Journal | Adiktologie |
| Volume | 16 |
| Issue number | 1 |
| Publication status | Published - 2016 |
| Externally published | Yes |
Keywords
- Dual diagnosis
- Methamphetamine
- Pervitin
- Psychiatric comorbidity